Literature DB >> 34035386

Deep learning for large scale MRI-based morphological phenotyping of osteoarthritis.

Nikan K Namiri1, Jinhee Lee1, Bruno Astuto1, Felix Liu1, Rutwik Shah1, Sharmila Majumdar1, Valentina Pedoia2.   

Abstract

Osteoarthritis (OA) develops through heterogenous pathophysiologic pathways. As a result, no regulatory agency approved disease modifying OA drugs are available to date. Stratifying knees into MRI-based morphological phenotypes may provide insight into predicting future OA incidence, leading to improved inclusion criteria and efficacy of therapeutics. We trained convolutional neural networks to classify bone, meniscus/cartilage, inflammatory, and hypertrophy phenotypes in knee MRIs from participants in the Osteoarthritis Initiative (n = 4791). We investigated cross-sectional association between baseline morphological phenotypes and baseline structural OA (Kellgren Lawrence grade > 1) and symptomatic OA. Among participants without baseline OA, we evaluated association of baseline phenotypes with 48-month incidence of structural OA and symptomatic OA. The area under the curve of bone, meniscus/cartilage, inflammatory, and hypertrophy phenotype neural network classifiers was 0.89 ± 0.01, 0.93 ± 0.03, 0.96 ± 0.02, and 0.93 ± 0.02, respectively (mean ± standard deviation). Among those with no baseline OA, bone phenotype (OR: 2.99 (95%CI: 1.59-5.62)) and hypertrophy phenotype (OR: 5.80 (95%CI: 1.82-18.5)) each respectively increased odds of developing incident structural OA and symptomatic OA at 48 months. All phenotypes except meniscus/cartilage increased odds of undergoing total knee replacement within 96 months. Artificial intelligence can rapidly stratify knees into structural phenotypes associated with incident OA and total knee replacement, which may aid in stratifying patients for clinical trials of targeted therapeutics.

Entities:  

Year:  2021        PMID: 34035386     DOI: 10.1038/s41598-021-90292-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  2 in total

Review 1.  Subchondral bone changes and the impacts on joint pain and articular cartilage degeneration in osteoarthritis.

Authors:  Degang Yu; Jiawei Xu; Fengxiang Liu; Xiaoqing Wang; Yuanqing Mao; Zhenan Zhu
Journal:  Clin Exp Rheumatol       Date:  2016-08-31       Impact factor: 4.473

2.  Longitudinal Change in Knee Cartilage Thickness and Function in Subjects with and without MRI-Diagnosed Cartilage Damage.

Authors:  Anna Wisser; Andreas Lapper; Frank Roemer; David Fuerst; Susanne Maschek; Wolfgang Wirth; Georg N Duda; Felix Eckstein
Journal:  Cartilage       Date:  2020-12-24       Impact factor: 3.117

  2 in total
  1 in total

Review 1.  FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit.

Authors:  Jason S Kim; Silvana Borges; Daniel J Clauw; Philip G Conaghan; David T Felson; Thomas R Fleming; Rachel Glaser; Elizabeth Hart; Marc Hochberg; Yura Kim; Virginia B Kraus; Larissa Lapteva; Xiaojuan Li; Sharmila Majumdar; Timothy E McAlindon; Ali Mobasheri; Tuhina Neogi; Frank W Roemer; Rebecca Rothwell; Robert Shibuya; Jeffrey Siegel; Lee S Simon; Kurt P Spindler; Nikolay P Nikolov
Journal:  Semin Arthritis Rheum       Date:  2022-07-14       Impact factor: 5.431

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.